相关实验视频
Updated: Jun 23, 2025

Monitoring Stub1-Mediated Pexophagy
Published on: May 12, 2023
过氧体增殖器激活的受体:瘤进展和生长的关键调节者
Fereshteh Asgharzadeh1, Arghavan Memarzia1, Vida Alikhani2
1Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
过氧酶增殖器激活受体 (PPARs) 影响癌症的进展. 这次审查探讨了PPARs.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症仍然是全球主要的死亡原因.
- 过氧体增殖器激活受体 (PPARs),包括PPARα,PPARδ和PPARγ,是核受体.
- PPARs在调节癌细胞增殖,生存,亡和瘤生长方面发挥着至关重要的作用.
研究的目的:
- 审查PPARs在癌症治疗中的agonists和antagonists的现有和潜在的未来应用.
- 阐明PPAR异型在不同组织和带特异性的瘤进展中的复杂作用.
主要方法:
- 在PubMed,Science Direct和Scopus数据库中进行全面的文献搜索.
- 专注于研究PPARs对各种癌症类型的影响.
- 包括在2023年5月之前发表的体外,体内和临床研究.
主要成果:
- 评论文章表明,PPARs在广泛的癌症中具有显著的治疗影响.
- 来自体外,体内和临床研究的证据支持PPARs在癌症管理中的作用.
结论:
- 对于各种恶性瘤来说,PPARs是有前途的治疗标.
- 需要进一步进行广泛的实验和临床研究,以充分理解和利用PPARs在不同类型癌症的影响.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Peroxisomes
Abnormal Proliferation
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...